. Author manuscript; available in PMC: 2013 Mar 27.

Published in final edited form as: J Am Coll Cardiol. 2012 Mar 27;59(13):1150–1158. doi: 10.1016/j.jacc.2011.12.022

Table 2.

Clinical and hemodynamic indices stratified by median asymmetric dimethylarginine (ADMA, 1.29 μM) and median global arginine bioavailability ratio (GABR, 0.9) in patients with advanced decompensated heart failure.

	ADMA			GABR
Parameters	< 1.29 μM (n=34)	≥ 1.29 μM (n=34)	P value	< 0.90 (n=34)	≥ 0.90 (n=34)	P value
Age (years)	53 ± 13	58 ± 12	0.130	58 ± 10	53 ± 15	0.054
BNP (pg/mL)	1,125 [668–2,172]	1,492 [661–2,143]	0.556	1,279 [641–2,247]	1,431 [679–2,079]	0.654

Hemodynamic indices
sPAP (mmHg)	42 ± 12	54 ± 13	<0.001	53 ± 15	43 ± 11	0.002
PCWP (mmHg)	20 ± 7	22 ± 7	0.490	22 ± 7	20 ± 7	0.223
CVP (mmHg)	11 ± 6	15 ± 5	0.009	15 ± 6	12 ± 5	0.050
CI (L/min/1.73m²)	2.0 ± 0.8	2.1 ± 0.5	0.219	2.1 ± 0.8	2.1 ± 0.5	0.537

Abbreviations: BNP, B-type natriuretic peptide; sPAP, systolic pulmonary artery pressure; PCWP, pulmonary capillary wedge pressure; CVP, central venous pressure; CI, cardiac index.